Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase NA 1

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 7Colorectal Neoplasms 4Polyps 3Gastroesophageal Reflux 3Esophageal Neoplasms 3Stomach Neoplasms 2Rectal Neoplasms 2Hyperplasia 2Adenomatous Polyposis Coli 2Adenocarcinoma 2Upper Tract Urothelial Carcinoma 1Stomach Ulcer 1Stomach Diseases 1Squamous Cell Carcinoma of Head and Neck 1Polyposis, Gastric 1Pancreatic Pseudocyst 1Neoplasms 1Lung Neoplasms 1Laryngeal Neoplasms 1Head and Neck Neoplasms 1Fistula 1Esophagitis, Peptic 1Esophageal and Gastric Varices 1ENDOSCOPIC CHARACTERIZATION 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colonic Neoplasms 1Carcinoma 1Anastomotic Leak 1Adenomatous Polyps 1Adenoma 1

Interventions

Colonoscopy 4Endoscopy 3Eicosapentaenoic Acid 2Uterine Myomectomy 1Ursodeoxycholic Acid 1Telemedicine 1Suppositories 1Sennosides 1Restraint, Physical 1Propofol 1Narrow Band Imaging 1Midazolam 1Metoclopramide 1Folic Acid 1Fentanyl 1Erythromycin 1Diet, Fat-Restricted 1Diet 1Diatrizoate Meglumine 1Colonography, Computed Tomographic 1Clinical Chemistry Tests 1Cholecystectomy 1Cholecalciferol 1Celecoxib 1Calcium Carbonate 1CVD protocol 1Bisacodyl 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Polyps × Endoscopy × Clear all
NCT02754661 2019-10-01

TOPAZ

Medtronic - MITG

Phase NA Completed
320 enrolled 15 charts

Polyps

NCT00510692 2014-08-22

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

S.L.A. Pharma AG

Phase 2/3 Completed
58 enrolled 12 charts
Gastrointestinal

Hyperplasia, Adenomatous Polyposis Coli, Polyps

NCT00432913 2008-10-17

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

S.L.A. Pharma AG

Phase 2/3 Completed
120 enrolled

Hyperplasia, Polyps, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡